{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:42:34Z","timestamp":1784234554323,"version":"3.55.0"},"reference-count":28,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Haifa"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: While a few studies suggest that depigmentation tends to develop more frequently in patients with malignant melanoma (MM), the association between vitiligo and MM has been sparsely investigated in the setting of controlled studies. Methods: A population-based case\u2013control study compared 14,632 patients with vitiligo with 71,580 control subjects matched by age, sex, and ethnicity regarding the prevalence of preexisting MM. Logistic regression was used to calculate the odds ratio (OR) and 95% confidence intervals (CIs) of developing vitiligo both in univariate and multivariate models, adjusting for demographic variables and comorbidities. The OR was also stratified by age, sex, ethnicity, and ultraorthodox status. Results: The prevalence of preexisting MM was statistically comparable between individuals with vitiligo and controls (0.30% vs. 0.35%, respectively). In the general study population, a history of MM was not significantly associated with an elevated likelihood of developing vitiligo (multivariate OR, 1.03; CI 95%, 0.76\u20131.40). Among the Arab population, however, preexisting MM was associated with a sixfold-increased likelihood of subsequent vitiligo (univariate OR, 6.55; 95% CI, 1.46\u201329.27). Patients with vitiligo and comorbid MM were older at the onset of vitiligo, had a higher burden of comorbid conditions, and showed an overrepresentation of Jewish ancestry. Conclusions: A history of MM does not increase the probability of vitiligo in the general Israeli population, except among the Arab minority, who show a sixfold-elevated odds of vitiligo after MM. Further investigation is essential to gain deeper insights into this relationship.<\/jats:p>","DOI":"10.3390\/jcm14155546","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:25:11Z","timestamp":1754486711000},"page":"5546","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is a History of Malignant Melanoma Associated with Subsequent Vitiligo? Insights from a Population-Based Case\u2013Control Study"],"prefix":"10.3390","volume":"14","author":[{"given":"Talia","family":"Israel","sequence":"first","affiliation":[{"name":"School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa 3498838, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6670-7020","authenticated-orcid":false,"given":"Baruch","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Adelson School of Medicine, Ariel University, Ariel 40700, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naama T.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2323-3512","authenticated-orcid":false,"given":"Shany","family":"Sherman","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center\u2014Beilinson Hospital, Petach Tikva 4941492, Israel"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6148-0421","authenticated-orcid":false,"given":"Geffen","family":"Kleinstern","sequence":"additional","affiliation":[{"name":"School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa 3498838, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9971-9151","authenticated-orcid":false,"given":"Khalaf","family":"Kridin","sequence":"additional","affiliation":[{"name":"Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel"},{"name":"Unit of Dermatology and Skin Research Laboratory, Galilee Medical Center, Nahariya 2210001, Israel"},{"name":"L\u00fcbeck Institute of Experimental Dermatology, University of L\u00fcbeck, 23562 L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","article-title":"Melanoma","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jdin.2020.10.013","article-title":"The global burden of skin cancer: A longitudinal analysis from the Global Burden of Disease Study, 1990\u20132017","volume":"2","author":"Urban","year":"2021","journal-title":"JAAD Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_4","unstructured":"Central Bureau of Statistics (2024, November 13). The Statistical Abstract of Israel (2020), Available online: https:\/\/www.cbs.gov.il\/he\/publications\/doclib\/2020\/21.shnatonagriculture\/diagrams21.pdf."},{"key":"ref_5","unstructured":"Ben-Lesen, M., and Silverman, B.K.-B.L. (2024, August 09). Melanoma of the Skin in Israel: Updated Morbidity and Mortality Data, Available online: https:\/\/www.gov.il\/he\/pages\/melanoma-may-2023."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.3390\/curroncol31120568","article-title":"Braf-mutant melanomas: Biology and therapy","volume":"31","author":"Pelosi","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of Vitiligo and Associated Autoimmune Diseases in Caucasian Probands and Their Families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment. Cell Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: The Vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2332\/allergolint.11-OA-0303","article-title":"Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families","volume":"60","author":"Narita","year":"2011","journal-title":"Allergol Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"18, 1686","DOI":"10.1056\/NEJMoa0908547","article-title":"Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo","volume":"362","author":"Jin","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: Mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1196\/annals.1423.043","article-title":"Harnessing autoimmunity (vitiligo) to treat melanoma: A myth or reality?","volume":"1110","author":"Ram","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_15","unstructured":"Fisher, D.E., and Bastian, B.C. (2019). Melanoma, Springer Science+Business Media, LLC, Part of Springer Nature, Springer."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e0163806","DOI":"10.1371\/journal.pone.0163806","article-title":"The Prevalence of Vitiligo: A Meta-Analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS ONE"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/bjd\/ljae282","article-title":"The lifetime risk and impact of vitiligo across sociodemographic groups: A UK population-based cohort study","volume":"192","author":"Eleftheriadou","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamadermatol.2023.2162","article-title":"Incidence and Prevalence of Diagnosed Vitiligo According to Race and Ethnicity, Age, and Sex in the US","volume":"159","author":"Mastacouris","year":"2023","journal-title":"JAMA Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.det.2011.11.013","article-title":"Quality-of-life issues in vitiligo","volume":"30","author":"Bhandarkar","year":"2012","journal-title":"Dermatol Clin."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2307\/2137152","article-title":"Racial Variation in Reaction to Physical Stigma: A Study of Degree of Disturbance by Vitiligo Among Black and White Patients","volume":"32","author":"Porter","year":"1991","journal-title":"J. Health Soc. Behav."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","article-title":"Vitiligo in patients with metastatic melanoma: A good prognostic sign","volume":"9","author":"Nordlund","year":"1983","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40264-019-00875-6","article-title":"Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study","volume":"43","author":"Babai","year":"2020","journal-title":"Drug Saf."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1610-0387.2008.06755.x","article-title":"Vitiligo and melanoma-associated hypopigmentation (MAH):shared and discriminative features","volume":"6","author":"Hartmann","year":"2008","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Failla, C.M., Carbone, M.L., Fortes, C., Pagnanelli, G., and D\u2019atri, S. (2019). Melanoma and vitiligo: In good company. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20225731"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e054058","DOI":"10.1136\/bmjopen-2021-054058","article-title":"Validation and adaptation of the Charlson Comorbidity Index using administrative data from the Colombian health system: Retrospective cohort study","volume":"12","author":"Oliveros","year":"2022","journal-title":"BMJ Open"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/oxfordjournals.aje.a113439","article-title":"On the need for the rare disease assumption in case-control studies","volume":"116","author":"Greenland","year":"1982","journal-title":"Am. J. Epidemiol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Fr\u0105czek, A., Owczarczyk-Saczonek, A., and Placek, W. (2020). The Role of TRM Cells in the Pathogenesis of Vitiligo-A Review of the Current State-Of-The-Art. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103552"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.jid.2018.03.1511","article-title":"Inverse Relationship between Vitiligo-Related Genes and Skin Cancer Risk","volume":"138","author":"Wu","year":"2018","journal-title":"J. Investig. Dermatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/15\/5546\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:24:32Z","timestamp":1760034272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/15\/5546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":28,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14155546"],"URL":"https:\/\/doi.org\/10.3390\/jcm14155546","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]}}}